Grant Life Sciences (GLIF.OB) Enters Into A Memorandum Of Understanding With Diagnostic Technology Pty. Ltd. To Develop And Commercialize Grant's Cervical Cancer-Diagnostic Technology
4/12/2006 11:42:59 AM
LOS ANGELES--(BUSINESS WIRE)--April 12, 2006--Grant Life Sciences Inc.
The proposed deal would include upfront payment of $250,000 to Grant, plus ongoing royalties upon commercialization of the resulting product; also, DTL will conduct and fund all development costs, including clinical trials, associated with the commercialization of the products developed from Grant's cervical cancer diagnostic technology.
comments powered by